Get the Stockscreener App
0.585
21.12%
0.102
Plus Therapeutics Inc stock is traded at $0.585, with a volume of 12.07M.
It is up +21.12% in the last 24 hours and up +88.65% over the past month.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
See More
Previous Close:
$0.483
Open:
$0.5
24h Volume:
12.07M
Relative Volume:
0.45
Market Cap:
$35.39M
Revenue:
-
Net Income/Loss:
$-12.89M
P/E Ratio:
-0.2312
EPS:
-2.53
Net Cash Flow:
$-11.95M
1W Performance:
+10.42%
1M Performance:
+88.65%
6M Performance:
-52.82%
1Y Performance:
-67.50%
1-Day Range:
$0.4906
$0.585
1-Week Range:
$0.45
$0.6114
52-Week Range:
$0.1634
$2.3099
Plus Therapeutics Inc Stock (PSTV) Company Profile
Name
Plus Therapeutics Inc
Sector
Industry
Phone
737.255.7194
Address
4200 MARATHON BLVD., AUSTIN, TX
Compare PSTV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PSTV
Plus Therapeutics Inc
|
0.585 | 29.22M | 0 | -12.89M | -11.95M | -2.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | D. Boral Capital | Buy |
| Jan-25-21 | Initiated | Ladenburg Thalmann | Buy |
| Oct-16-20 | Initiated | Maxim Group | Buy |
Plus Therapeutics Inc Stock (PSTV) Latest News
How strong is Plus Therapeutics Inc. company’s balance sheetEarnings Report Planner For 2025 - jammulinksnews.com
Published on: 2025-08-01 22:18:13 - metal.it
Plus Therapeutics (PSTV.O) Surges 16.5% — What's Behind the Sharp Move? - AInvest
What are analysts’ price targets for Plus Therapeutics Inc. in the next 12 monthsStock Strategy Recommendation From AI Tools - jammulinksnews.com
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic - GlobeNewswire
What is the risk reward ratio of investing in Plus Therapeutics Inc. stockSmart Portfolio Recommendation For Beginners - jammulinksnews.com
Plus Therapeutics (PSTV) to Introduce CNSide Diagnostics in Texas by August 2025 - GuruFocus
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic | PSTV Stock News - GuruFocus
Revolutionary CNS Cancer Test With 92% Accuracy Launches at Major Texas Cancer Centers - Stock Titan
Is Plus Therapeutics Inc. stock overvalued or undervaluedReal Time Watchlist With Proven Results - jammulinksnews.com
What makes Plus Therapeutics Inc. stock price move sharplyReliable Alerts for Daily Stock Movers Released - metal.it
Plus Therapeutics (PSTV.O) Plunges 13%: Unpacking the Intraday Shock - AInvest
Institutional Tools Highlight Unusual Flow in Plus Therapeutics Inc.Watchlist for Smart Swing Trading Updated - metal.it
What is the dividend policy of Plus Therapeutics Inc. stockGet daily expert analysis for smarter investing - jammulinksnews.com
Does Plus Therapeutics Inc. stock perform well during market downturnsBuild wealth steadily with proven investment techniques - jammulinksnews.com
Why is Plus Therapeutics Inc. stock attracting strong analyst attentionAmplify your gains with low-risk picks - jammulinksnews.com
How does Plus Therapeutics Inc. generate profit in a changing economyBoost your wealth with consistent growth stocks - jammulinksnews.com
What catalysts could drive Plus Therapeutics Inc. stock higher in 2025Unlock rapid growth potential in your portfolio - jammulinksnews.com
How volatile is Plus Therapeutics Inc. stock compared to the marketConsistent wealth multiplication - jammulinksnews.com
Published on: 2025-07-27 20:49:15 - jammulinksnews.com
Healthcare Stocks Move in Intrday Session: Gainers and Losers - AInvest
What drives Plus Therapeutics Inc. stock priceOutstanding capital appreciation - PrintWeekIndia
What analysts say about Plus Therapeutics Inc. stockFree Stock Chart Pattern Guide - Autocar Professional
Should I buy Plus Therapeutics Inc. stock before earningsRecord-setting profit potential - jammulinksnews.com
Can Plus Therapeutics Inc. stock recover from recent declineFree Consultation - jammulinksnews.com
Plus Therapeutics Skyrockets 22.22%—What’s Fueling This Volatility? - AInvest
Plus Therapeutics Soars 32.65% on $1.6M CPRIT Payment - AInvest
Why Did Plus Therapeutics (PSTV) Soar 12.24%? - AInvest
Plus Therapeutics Soars 12.65% on $17.6M CPRIT Grant for Cancer Research - AInvest
Plus Therapeutics shares rise 12.86% premarket after receiving $1.6 million advance payment from CPRIT. - AInvest
Is Plus Therapeutics Inc. a good long term investmentPhenomenal returns - Autocar Professional
Plus Therapeutics (PSTV) Secures $1.6 Million Advance from Texas Institute - GuruFocus
Plus Therapeutics Soared 22.18%—What’s Next for This Biotech Breakout? - AInvest
Plus Therapeutics (PSTV) Receives $1.6M Advance from CPRIT Grant | PSTV Stock News - GuruFocus
Plus Therapeutics: Leveraging Non-Dilutive Funding to Accelerate CNS Cancer Innovation - AInvest
Plus Therapeutics Inc. Stock Analysis and ForecastBreakthrough stock performance - jammulinksnews.com
Plus Therapeutics Announces $1.6 Million Advance Payment from CP - GuruFocus
Plus Therapeutics (PSTV) Receives $1.6M Advance from CPRIT Grant - GuruFocus
Plus Therapeutics, Inc. Secures $1.6 Million Advance Payment from CPRIT to Support CNS Cancer Research and Development - Nasdaq
Plus Therapeutics receives $1.6 million advance from CPRIT grant - Investing.com
Plus Therapeutics receives $1.6 million advance from CPRIT grant By Investing.com - Investing.com UK
Plus Therapeutics Announces $1.6 Million Advance Payment from CPRIT - GlobeNewswire
Plus Therapeutics Inc Stock (PSTV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):